Myeloid and erythroid cell populations in the BM
. | Population size . | . | |
|---|---|---|---|
| BM subpopulation . | Control . | β1β7 mutant . | |
| Gr-1 | 50.7 ± 4.9 | 63.5 ± 11.0 | |
| Mac-1 | 64.4 ± 10.6 | 73.5 ± 14.2 | |
| Ter119+ | 19.3 ± 3.5 | 14.1 ± 8.6 | |
. | Population size . | . | |
|---|---|---|---|
| BM subpopulation . | Control . | β1β7 mutant . | |
| Gr-1 | 50.7 ± 4.9 | 63.5 ± 11.0 | |
| Mac-1 | 64.4 ± 10.6 | 73.5 ± 14.2 | |
| Ter119+ | 19.3 ± 3.5 | 14.1 ± 8.6 | |
For both populations, n = 4. Single-cell suspensions from BM of control and β1β7 mutant BM chimeras 2 months after polylC treatment were prepared; stained with antibodies against Gr-1, Mac-1, and Ter119 in combination with antibodies against β1 integrin; and analyzed in FACS. The table shows the relative size of granulocyte (Gr-1), granulocyte/monocyte (Mac-1), and erythroblast (Ter119) subpopulations and standard deviation.